Publications in collaboration with researchers from GlaxoSmithKline (United Kingdom) (1)

2020

  1. Hakin-1, a new specific small-molecule inhibitor for the E3 ubiquitin-ligase Hakai, inhibits carcinoma growth and progression

    Cancers, Vol. 12, Núm. 5